SEC Form 4 · accession 0001179110-15-000195
Ocata Therapeutics, Inc. · OCAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Langer
Director
Period of report
Jan 2, 2015
Accepted (ET)
Jan 5, 2015 · 4:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001140098
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $6.39 | Jan 2, 2015 | A | 5,000 | A | Jan 2, 2015 | Jan 1, 2025 | Common Stock | 5,000 | 5,000 | D |